BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 15897878)

  • 1. Integrin alpha6beta4 promotes expression of autotaxin/ENPP2 autocrine motility factor in breast carcinoma cells.
    Chen M; O'Connor KL
    Oncogene; 2005 Jul; 24(32):5125-30. PubMed ID: 15897878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrin alpha6beta4 controls the expression of genes associated with cell motility, invasion, and metastasis, including S100A4/metastasin.
    Chen M; Sinha M; Luxon BA; Bresnick AR; O'Connor KL
    J Biol Chem; 2009 Jan; 284(3):1484-94. PubMed ID: 19011242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrin (alpha6beta4) signals through Src to increase expression of S100A4, a metastasis-promoting factor: implications for cancer cell invasion.
    Kim TH; Kim HI; Soung YH; Shaw LA; Chung J
    Mol Cancer Res; 2009 Oct; 7(10):1605-12. PubMed ID: 19808905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1.
    Hama K; Aoki J; Fukaya M; Kishi Y; Sakai T; Suzuki R; Ohta H; Yamori T; Watanabe M; Chun J; Arai H
    J Biol Chem; 2004 Apr; 279(17):17634-9. PubMed ID: 14744855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of autotaxin production or activity blocks lysophosphatidylcholine-induced migration of human breast cancer and melanoma cells.
    Gaetano CG; Samadi N; Tomsig JL; Macdonald TL; Lynch KR; Brindley DN
    Mol Carcinog; 2009 Sep; 48(9):801-9. PubMed ID: 19204929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of autotaxin by the Epstein-Barr virus promotes the growth and survival of Hodgkin lymphoma cells.
    Baumforth KR; Flavell JR; Reynolds GM; Davies G; Pettit TR; Wei W; Morgan S; Stankovic T; Kishi Y; Arai H; Nowakova M; Pratt G; Aoki J; Wakelam MJ; Young LS; Murray PG
    Blood; 2005 Sep; 106(6):2138-46. PubMed ID: 15933052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysophospholipids in the limelight: autotaxin takes center stage.
    Moolenaar WH
    J Cell Biol; 2002 Jul; 158(2):197-9. PubMed ID: 12135981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression, regulation and function of autotaxin in thyroid carcinomas.
    Kehlen A; Englert N; Seifert A; Klonisch T; Dralle H; Langner J; Hoang-Vu C
    Int J Cancer; 2004 May; 109(6):833-8. PubMed ID: 15027116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production.
    Umezu-Goto M; Kishi Y; Taira A; Hama K; Dohmae N; Takio K; Yamori T; Mills GB; Inoue K; Aoki J; Arai H
    J Cell Biol; 2002 Jul; 158(2):227-33. PubMed ID: 12119361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of NFAT transcription factors in integrin-mediated carcinoma invasion.
    Jauliac S; López-Rodriguez C; Shaw LM; Brown LF; Rao A; Toker A
    Nat Cell Biol; 2002 Jul; 4(7):540-4. PubMed ID: 12080349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The candidate tumor suppressor CST6 alters the gene expression profile of human breast carcinoma cells: down-regulation of the potent mitogenic, motogenic, and angiogenic factor autotaxin.
    Song J; Jie C; Polk P; Shridhar R; Clair T; Zhang J; Yin L; Keppler D
    Biochem Biophys Res Commun; 2006 Feb; 340(1):175-82. PubMed ID: 16356477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of autotaxin (NPP-2) is closely linked to invasiveness of breast cancer cells.
    Yang SY; Lee J; Park CG; Kim S; Hong S; Chung HC; Min SK; Han JW; Lee HW; Lee HY
    Clin Exp Metastasis; 2002; 19(7):603-8. PubMed ID: 12498389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of autotaxin as a neurite retraction-inducing factor of PC12 cells in cerebrospinal fluid and its possible sources.
    Sato K; Malchinkhuu E; Muraki T; Ishikawa K; Hayashi K; Tosaka M; Mochiduki A; Inoue K; Tomura H; Mogi C; Nochi H; Tamoto K; Okajima F
    J Neurochem; 2005 Feb; 92(4):904-14. PubMed ID: 15686493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTH-related protein upregulates integrin alpha6beta4 expression and activates Akt in breast cancer cells.
    Shen X; Falzon M
    Exp Cell Res; 2006 Nov; 312(19):3822-34. PubMed ID: 16965770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The alpha6beta4 integrin maintains the survival of human breast carcinoma cells in vivo.
    Lipscomb EA; Simpson KJ; Lyle SR; Ring JE; Dugan AS; Mercurio AM
    Cancer Res; 2005 Dec; 65(23):10970-6. PubMed ID: 16322245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential involvement of adipocyte insulin resistance in obesity-associated up-regulation of adipocyte lysophospholipase D/autotaxin expression.
    Boucher J; Quilliot D; Pradères JP; Simon MF; Grès S; Guigné C; Prévot D; Ferry G; Boutin JA; Carpéné C; Valet P; Saulnier-Blache JS
    Diabetologia; 2005 Mar; 48(3):569-77. PubMed ID: 15700135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of cAMP gating by the alpha6beta4 integrin stimulates lamellae formation and the chemotactic migration of invasive carcinoma cells.
    O'Connor KL; Shaw LM; Mercurio AM
    J Cell Biol; 1998 Dec; 143(6):1749-60. PubMed ID: 9852165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autotaxin protects MCF-7 breast cancer and MDA-MB-435 melanoma cells against Taxol-induced apoptosis.
    Samadi N; Gaetano C; Goping IS; Brindley DN
    Oncogene; 2009 Feb; 28(7):1028-39. PubMed ID: 19079345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autotaxin/lysopholipase D and lysophosphatidic acid regulate murine hemostasis and thrombosis.
    Pamuklar Z; Federico L; Liu S; Umezu-Goto M; Dong A; Panchatcharam M; Fulkerson Z; Berdyshev E; Natarajan V; Fang X; van Meeteren LA; Moolenaar WH; Mills GB; Morris AJ; Smyth SS
    J Biol Chem; 2009 Mar; 284(11):7385-94. PubMed ID: 19139100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of lysophosphatidic acid in blister fluid: involvement of a lysophospholipase D activity.
    Mazereeuw-Hautier J; Gres S; Fanguin M; Cariven C; Fauvel J; Perret B; Chap H; Salles JP; Saulnier-Blache JS
    J Invest Dermatol; 2005 Sep; 125(3):421-7. PubMed ID: 16117781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.